In vitro and in vivo suppression of cellular activity by GUANIDINOETHYL DISULFIDE (cas 1072-13-5) released from hydrogel microspheres composed of partially oxidized hyaluronan and gelatin

Add time:07/25/2019    Source:sciencedirect.com

This paper describes the preparation of oxidized hyaluronan crosslinked gelatin microspheres for drug delivery. Microspheres were prepared by a modified water-in-oil-emulsion crosslinking method, where three-dimensional crosslinked hydrogel microspheres formed in the absence of any extraneous crosslinker. SEM analyses of the microspheres showed rough surfaces in their dried state with an average diameter of 90 μm. Lyophilization of fully swollen microspheres revealed a highly porous structure. GUANIDINOETHYL DISULFIDE (cas 1072-13-5) (GED) was used as a model drug for incorporation into the microspheres; encapsulation of GED was confirmed by HPLC. There was an inverse correlation between the diameters of the microspheres with their GED loading. Macrophage was used as a model cell to evaluate the in vitro efficacy of GED release from the microspheres. The in vivo efficacy of the microspheres was further validated in a mouse full-thickness transcutaneous dermal wound model through suppression of cell infiltration.

We also recommend Trading Suppliers and Manufacturers of GUANIDINOETHYL DISULFIDE (cas 1072-13-5). Pls Click Website Link as below: cas 1072-13-5 suppliers

Prev:Design, synthesis and 64Cu labeling of fatty acid analogs containing dithiosemicarbazone chelate
Next:Structure of poly(di-N-HEXYLSILANE (cas 1072-14-6)) in nanoporous materials)